CANF EBITDA Margin

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · EBITDA Margin

CANF EBITDA Margin

Latest reported-2402.47%period endingJun 30, 2026

CANF EBITDA Margin (-473.07% → -2402.47%)

Annual ebitda margin

Share image ↗High-resolution chart · PNG

CANF ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares EBITDA Margin — Annual fiscal periods

Period ending	EBITDA Margin
Dec 31, 2025	-2,450.8694%
Dec 31, 2024	-1,205.1929%
Dec 31, 2023	-1,100.9421%
Dec 31, 2022	-1,244.6914%
Dec 31, 2021	-1,503.8687%
Dec 31, 2020	-1,851.5072%
Dec 31, 2019	-590.2067%
Dec 31, 2018	-160.3665%
Dec 31, 2017	-848.3023%
Dec 31, 2016	-5,119.174%
Dec 31, 2015	-3,884.6085%
Dec 31, 2014	0%
Dec 31, 2013	0%
Dec 31, 2012	0%
Dec 31, 2011	-1,563.5305%
Dec 31, 2010	-473.0715%